Everything you need to win Ixico PLC — in one platform.
Who to reach, what to say, and why now on Ixico PLC — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Ixico PLC — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Ixico signs new contract for Phase 2 Huntington's Disease clinical trial
Dec 10, 2024•over 1 year ago
Contract Type
contract
LondonBiotechnologyHealth CareMedical
Description
Ixico has secured a new contract with a US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial, with a contract value worth more than £500,000 over approximately two and a half years. This contract reinforces Ixico's expertise in supporting neurodegenerative disease trials and aligns with its strategic pillars for expansion and growth.
Company Information
Company
Ixico PLC
Location
London, England, United Kingdom
About
Ixico PLC is a London-based medical analytics company focused on accelerating the growth and global commercial reach of neurology technology platforms, addressing unmet clinical needs in neurological diseases, and developing and scaling product offerings across areas of drug development.
LondonBiotechnologyHealth CareMedical